Health

New Data, iCARE Study: Hailie® Smartinhaler® Powers Unprecedented Medication Adherence in Patients with COPD and Asthma

Highlights: * Up to 235% increase in real-world adherence compared to published norms (20–40%), across ~850 chronic obstructive pulmonary disease (COPD) and asthma patients. * >60% patients achieved an average two-week baseline adherence with ~4 in 10 patients reaching the critical threshold...

2025-09-15 12:05 1796

MGI Tech Introduces DNBSEQ-T7+: A Next-Generation 'Data Mining Machine' for Genomics

SHENZHEN, China, Sept. 15, 2025 /PRNewswire/ -- MGI Tech Co., Ltd. (MGI), a company dedicated to developing core tools and technologies that drive innovation in life sciences, announced the launch of the DNBSEQ-T7+, its latest high-throughput sequencer. Designed to meet the rising demand for larg...

2025-09-15 11:53 1777

Lion TCR Achieves Triple FDA Milestones with IND Clearance for Chronic Hepatitis B Following Earlier Fast Track and Orphan Drug Designations

SINGAPORE and GUANGZHOU, China, Sept. 15, 2025 /PRNewswire/ -- Lion TCR, a clinical-stage biotechnology company pioneering T-cell receptor (TCR)-based therapies, today announced that it has received Investigational New Drug (IND) clearance from the U.S. Food and Drug Administration (FDA) to initi...

2025-09-15 08:00 1596

EverBridge Group and Cosmotec Forge Landmark Partnership

SHANGHAI, Sept. 15, 2025 /PRNewswire/ -- EverBridge Group announced an Exclusive Commercialization Partnership with Cosmotec Inc. (a Wholly Owned Subsidiary of M3, Inc.; TSE: 2413) for the Japanese market. Jay Wang (Left) and Suguru Ominato ...

2025-09-15 08:00 2701

Real-World Evidence of NEFECON® to Be Presented in Seven New Abstracts at the 18th International lgAN Symposium

* 7 new NEFECON® real-world evidence abstracts will be presented at the 18th  International lgA Nephropathy Symposium (IIgANN 2025). * The newly released results, based on clinical practices at several leading hospitals inChina, offer a comprehensive overview of the efficacy and safety of NEFE...

2025-09-15 07:45 4801

Senna Wellness Retreat introduces art showcase 'Trăng Lên Đỉnh Núi': A mid-autumn tribute to Kinh Bắc's beauty and community spirit

BAC NINH, Vietnam, Sept. 13, 2025 /PRNewswire/ -- From 12 to 21 September 2025, Senna Wellness Retreat presents the art showcase 'Trăng Lên Đỉnh Núi' to embrace its Mid-Autumn campaign's message of festive togetherness. Set against the breathtaking backdrop ofNorthern Vietnam, the showcase invite...

2025-09-13 16:35 4273

/C O R R E C T I O N -- Mars/

In the news release, Mars Snacking and Unreasonable Group Welcome Fourteen New Ventures to Unreasonable Food™, issued11-Sep-2025 by Mars over PR Newswire, we are advised by the company that the release has been updated to include the full 2025 Unreasonable Food cohort. The complete, corrected rel...

2025-09-13 06:14 5124

WFH mobilizes global community to achieve milestone revisions to WHO EML

MONTREAL, Sept. 12, 2025 /PRNewswire/ -- A concerted effort by the World Federation of Hemophilia (WFH) and its partners has led to the World Health Organization (WHO) updating its Essential Medicines List (EML) and the Essential Medicines List for Children (EMLc) to better align the EMLs to the ...

2025-09-12 21:42 1611

Pulnovo Medical Receives two IDE approvals for PADN system's clinical trials with CMS coverage

SHANGHAI, Sept. 12, 2025 /PRNewswire/ -- Pulnovo Medical, a globally recognized leader in medical devices for pulmonary hypertension (PH) and heart failure (HF), is proud to announce that its PADN catheter and generator has receivedtwo Investigational Device Exemption (IDE) approvals—HDE study ap...

2025-09-12 18:23 1914

3Shape Announces Leadership Transition: Rune Fisker Appointed External Executive Advisor to CEO After 25 Years of Pioneering Innovation

COPENHAGEN, Denmark, Sept. 12, 2025 /PRNewswire/ -- 3Shape today announced a leadership transition that honors one of its most influential innovators. After 25 years at the forefront of 3Shape's journey, Rune Fisker, Senior Vice President of Product Strategy, will step down from his current role ...

2025-09-12 15:47 2176

Nexus Aesthetic Clinic Founder Dr. Samantha Tay Advocates for Enhanced Patient Safety in Aesthetic Medicine

Founder of Nexus Aesthetic Clinic addresses public concerns about injectables and highlights the importance of professional oversight. SINGAPORE, Sept. 12, 2025 /PRNewswire/ -- Amid a growing public conversation about the safety and efficacy of aesthetic procedures, Dr.Samantha Tay, founder of N...

2025-09-12 15:08 2753

Prioritizing Quality and Patient Safety with Digital Transformation, RS Pondok Indah Group Becomes First in Indonesia to Achieve HIMSS EMRAM Stage 7

Setting new standards in healthcare quality and patient safety through digital transformation. JAKARTA, Indonesia, Sept. 12, 2025 /PRNewswire/ -- RS Pondok Indah Group (Pondok Indah Hospital Group) has made history as the first hospital group in Indonesia to achieve the HIMSS Electronic Medical R...

2025-09-12 14:14 3775

Indication Expansion Accelerates: First Patient Dosed in Melanoma Phase 1b/II Trial of Opamtistomig

NANJING, China, Sept. 12, 2025 /PRNewswire/ -- Nanjing Leads Biolabs Co., Ltd. ("Leads Biolabs" or the "Company," Stock Code: 9887.HK) today announced the first patient has been successfully dosed in a Phase1b/II clinical trial (NCT07099430) evaluating Opamtistomig (LBL-024, PD-L1/4-1BB bispecifi...

2025-09-12 12:39 1704

The New Drug Application for KN026 (Anbenitamab Injection) Has Been Accepted by the National Medical Products Administration

SUZHOU, China, Sept. 12, 2025 /PRNewswire/ -- Alphamab Oncology (Stock Code: 9966.HK) announced that the New Drug Application (NDA) for anbenitamab injection (KN026), independently developed by the Company and co-developed with JMT-Bio Technology Co., Ltd., a wholly-owned subsidiary of CSPC Pharm...

2025-09-12 09:51 1558

Psoriatic Disease To Take Center Stage at the UN General Assembly: IFPA Calls for Greater Recognition of Psoriatic Disease During UN High-Level Meetings

STOCKHOLM, Sept. 12, 2025 /PRNewswire/ -- The International Federation of Psoriasis Associations (IFPA) spotlights psoriatic disease at the upcoming UNGA 80 inNew York, where world leaders are expected to adopt a new Political Declaration on noncommunicable diseases (NCDs), mental health and well...

2025-09-12 00:16 2051

GLOBAL FIRST "High-Definition Image": Decoding the "Code of Youth" - LivingPhoenix's POGMENT Collagen Breakthrough Bridges International Gap

CHENGDU, China, Sept. 11, 2025 /PRNewswire/ -- Recently, LivingPhoenix®Regenerative Technologies Development (Chengdu) Co., Ltd., announced that its self-developed POGMENT triple-helix biomimetic collagen has, for the first time globally, achieved high-resolution molecular visualization of "coll...

2025-09-11 20:26 2006

Lundbeck showcases new clinical migraine data, including long-term preventive effectiveness of Vyepti® (eptinezumab) in patients severely impacted by migraine

* Lundbeck demonstrates leadership and unwavering commitment to advancing migraine management and supporting patient outcomes with six presentations at the 2025 International Headache Congress (IHC), including three oral presentations on eptinezumab (Vypeti®) and Lu AG09222 (anti-PACAP mAb) *...

2025-09-11 14:56 1415

HaemaLogiX wins "Most Promising CAR-T Pipeline in APAC" at the Asia Pacific CGT¹ Excellence Awards 2025

SYDNEY, Sept. 11, 2025 /PRNewswire/ -- HaemaLogiX Ltd, a clinical stage Australian biotech, developing novel immunotherapies for patients with blood cancers and B-cell diseases, was honoured to be awarded the"Most Promising CAR-T Pipeline in APAC" at the Asia Pacific CGT Excellence Awards 2025, h...

2025-09-11 11:52 1806

Amaran Biotech Wins Asia-Pacific Biologics CDMO Excellence Award for "Best Fill-Finish"

50-Person Team Demonstrates Taiwan's Biotech Strength HSINCHU, Sept. 11, 2025 /PRNewswire/ -- Amaran Biotech, a next-generation Contract Development and Manufacturing Organization (CDMO), was awarded the "Best Fill-Finish" at the 2025 Asia-Pacific Biologics CDMO Excellence Awards held inSingapore...

2025-09-11 10:00 2104

SynbioTech's TWK10 Approved to Boost Muscle Strength, The Probiotic Pioneer Marches Toward Southeast Asia Market

BANGKOK, Sept. 11, 2025 /PRNewswire/ -- SynbioTech Inc., ranked among the world's top 20 probiotic suppliers, is the leader in functional probiotics for muscle and joint health, sports, women's wellness, and immune support. Its patented flagship probiotic,Lactiplantibacillus plantarum TWK10®, has...

2025-09-11 10:00 2218
1 ... 34353637383940 ... 559